|Articles|February 15, 2022

Exploring New Research In Viral Inactivation

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Accelerate Your Biologic with HEK Cell Lines

ByCatalent

January 2nd 2026

Long-Term Performance and Stability of TOYOPEARL Super A over 200 Cleaning Cycles

ByTosoh Bioscience

December 16th 2025

Two-Step Monoclonal Antibody Purification Using a Multi-Column Continuous Chromatography Platform

ByTosoh Bioscience

December 16th 2025

Single-Use Components and Assemblies for Critical Bioprocess Steps and Various Biopharmaceutical Modalities: Including ADCs and More

BySaint-Gobain

December 16th 2025

Process Optimization for High Purity mAb Recovery

ByTosoh Bioscience

December 16th 2025

Exploring New Research In Viral Inactivation

Newsletter

Related Content

Accelerate Your Biologic with HEK Cell Lines

Long-Term Performance and Stability of TOYOPEARL Super A over 200 Cleaning Cycles

Two-Step Monoclonal Antibody Purification Using a Multi-Column Continuous Chromatography Platform

Single-Use Components and Assemblies for Critical Bioprocess Steps and Various Biopharmaceutical Modalities: Including ADCs and More

Process Optimization for High Purity mAb Recovery

Trending on BioPharm International

CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics

Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease

China Approves First Monthly Biologic for COPD

FUJIFILM Irvine Scientific Rebrands as FUJIFILM Biosciences